XML 70 R53.htm IDEA: XBRL DOCUMENT
v3.25.3

Description of Business - Schedule of Consolidated Financial Statements (Details) | 12 Months Ended
--- | ---
Jul. 31, 2025
Broad Atlantic Associates, LLC [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 100.00% |
IDT R.E. Holdings Ltd. [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | Israel |
Percentage Owned | 100.00% |
Rafael Holdings Realty, Inc. [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 100.00% |
Barer Institute, Inc. [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 100.00% | [1]
Hillview Avenue Realty, JV [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 100.00% |
Hillview Avenue Realty, LLC [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 100.00% |
Rafael Medical Devices, LLC [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 73.00% |
Farber Partners, LLC [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 93.00% |
Pharma Holdings, LLC [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 90.00% | [2]
LipoMedix Pharmaceuticals Ltd. [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | Israel |
Percentage Owned | 95.00% |
Altira Capital & Consulting, LLC [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 67.00% |
CS Pharma Holdings, LLC [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 45.00% | [2]
Day Three Labs, Inc.[Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 84.00% |
Cornerstone Pharmaceuticals, Inc.[Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 67.00% |
RP Finance, LLC [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Delaware |
Percentage Owned | 38.00% |
Cyclo Therapeutics, LLC [Member] |  |
Schedule of Consolidated Financial Statements [Line Items] |  |
Country of Incorporation | United States – Nevada |
Percentage Owned | 100.00% |
[1] | In November 2022, the Company resolved to curtail its early-stage development efforts, including pre-clinical research at Barer. The decision was taken to reduce spending as the Company focuses on exploring strategic opportunities.
[2] | 50% of CS Pharma Holdings, LLC is owned by Pharma Holdings, LLC. We have a 90% ownership interest in Pharma Holdings, LLC and, therefore, an effective 45% economic interest in CS Pharma Holdings, LLC. The Company, along with CS Pharma Holdings, LLC and Pharma Holdings LLC, collectively own securities representing 67% of the outstanding capital stock of Cornerstone.

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of units or percentage investment held in the subsidiary by the limited liability company or limited partnership. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition State in which the subsidiary of the limited liability company or limited partnership was organized. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipState
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_OwnershipAxis=rfl_BroadAtlanticAssociatesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_IDTREHoldingsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_RafaelRealtyHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_BarerInstituteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_HillviewAvenueRealtyJVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_HillviewAvenueRealtyLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_RafaelMedicalDevicesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_FarberPartnersLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_PharmaHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_LipoMedixPharmaceuticalsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_AltiraCapitalConsultingLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_CSPharmaHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_DayThreeLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_CornerstonePharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_RPFinanceLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_CycloTherapeuticsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |